Education Use Only
For educational use only — Not for clinical decision-making without independent verification
Medical Associates  ·  Department of Nephrology ← urinenephrology.org
Nephrology Education Series

Edema Evaluation: Generalized vs Localized, Nephrotic vs Cardiac vs Hepatic

Andrew Bland, MD, FACP, FAAP UICOMP · UDPA · Butler COM 2026-02-28 10 min read

Edema Evaluation: Generalized vs Localized, Nephrotic vs Cardiac vs Hepatic

Definition & Pathophysiology: Starling Forces

Edema = Abnormal accumulation of fluid in interstitial space (outside cells, outside intravascular)

Starling Equation Governs Fluid Movement

Net Filtration Force = (Pc - Pi) - (πc - πi)
                     = Hydrostatic gradient - Oncotic gradient

Where: - Pc = Capillary hydrostatic pressure (pushes fluid OUT) - Pi = Interstitial hydrostatic pressure (pushes fluid IN) — usually ~0, less important - πc = Capillary oncotic pressure (pulls fluid IN) — mainly from albumin - πi = Interstitial oncotic pressure (pulls fluid OUT)

For edema to develop, ONE of these must occur: 1. ↑ Capillary hydrostatic pressure (Pc ↑) — venous obstruction, right-sided HF 2. ↓ Capillary oncotic pressure (πc ↓) — hypoalbuminemia (nephrotic syndrome, cirrhosis, malnutrition) 3. ↑ Interstitial oncotic pressure (πi ↑) — increased protein leak to interstitium (inflammation, capillary leak) 4. ↓ Lymphatic drainage — obstruction, malignancy, infection

Clinical Pearl

Quick decision tree: - Edema present + LOW albumin → nephrotic syndrome or liver disease (usually) - Edema present + NORMAL albumin → cardiac/renal sodium retention or lymphatic obstruction (usually)


Generalized Edema (Whole Body)

Nephrotic Syndrome (~1.5% prevalence in general population)

Definition: Proteinuria >3.5 g/day + hypoalbuminemia + hyperlipidemia + edema

Primary causes (60%): - FSGS (focal segmental glomerulosclerosis) — 40% - Membranous nephropathy — 20% - Minimal change disease — 15% - IgA nephropathy — 10% - Other GN — 15%

Secondary causes (40%): - Diabetes mellitus (~50% of secondary) - SLE (~10%) - Infection (HIV, HCV, syphilis) — 5–10% - Malignancy (solid tumors, hematologic) — 10% - Amyloidosis, light chain disease — 5–10% - Drugs (NSAIDs, INH, heroin) — 5% - Allergic (pollen, insect venom) — rare

Pathophysiology: - Heavy proteinuria (>3.5 g/day) → protein loss exceeds synthesis - ↓ Plasma oncotic pressure (πc ↓ from low albumin) - Edema results from Starling force imbalance - Secondary effects: - Hepatic compensatory albumin synthesis ↑ (but overwhelmed) - Liver synthesizes more apoB → ↑ cholesterol, ↑ LDL (nephrotic hyperlipidemia) - Proteinuria includes iron-binding proteins → iron loss → anemia - Loss of anticoagulant proteins (antithrombin III, protein S) → thrombosis risk ↑↑

Clinical Features: - Edema (pitting, symmetric): Periorbital (morning worst), lower extremities - Weight gain: Often 5–15 lbs overnight from fluid retention - Foamy urine: Proteinuria visible as foam - Lipiduria: “Oval fat bodies” on UA (lipid-laden tubular cells; pathognomonic if present)

Labs: - Albumin <2.5 g/dL (marked hypoalbuminemia) - Proteinuria 3.5–15 g/day (can range) - Cholesterol >300 mg/dL (nephrotic hyperlipidemia) - Complement: Variable (normal in FSGS; ↓C3 in PSGN/ANCA)

Complications: - Infection: ↓ Immunoglobulin loss; asplenic-like state (S. pneumoniae risk ↑) - Thrombosis: VTE, PE, renal vein thrombosis (RVT) — hypercoagulable from loss of anticoagulants + ↑ fibrinogen - Hypertension: From fluid retention - AKI: From volume depletion if diuretics too aggressive, or renal artery stenosis (if membranous on anticoagulation)

Management: 1. Identify cause: Serologies, imaging (kidney biopsy if diagnosis uncertain) 2. Reduce proteinuria: - ACE-I/ARB first-line (reduce intraglomerular pressure) - SGLT2 inhibitor (emerging; dapagliflozin reduces nephrotic proteinuria) - Finerenone (if CKD + proteinuria) 3. Edema control: - Sodium restriction: <2 g/day (reduces volume retention) - Diuretics: Furosemide (high-dose often needed; large proteinuria impairs diuretic secretion in tubules) - Caution: Overly aggressive diuresis → AKI (RVT risk if membranous) 4. Monitor & prevent complications: - Anticoagulation if RVT risk (SQ LMWH or warfarin if membranous) - Statin for nephrotic lipids - Pneumococcal vaccine + prophylaxis (splenectomy-like protection)


Congestive Heart Failure (CHF) / Acute Decompensated Heart Failure (ADHF)

Mechanism: Right-sided HF → venous congestion → ↑ Pc (hydrostatic pressure ↑)

Pathophysiology: - Impaired ventricular emptying → ↑ LV diastolic pressure → ↑ LA pressure → ↑ pulmonary vein pressure → ↑ capillary Pc - Backward flow → systemic venous congestion → hepatomegaly → ↑ JVP - Neurohormonal activation: RAAS ↑, SNS ↑ → Na retention → ↑ preload (further worsens HF)

Clinical Features: - Peripheral edema: Bilateral, gravity-dependent (worse in ankles/legs standing; sacral if bedbound) - Orthopnea, PND: Pulmonary edema from ↑ pulmonary capillary pressure - Elevated JVP: Hepatic venous congestion - Hepatomegaly: RV pressure transmits to liver - Weight gain: Acute (overnight gains 2–5 lbs = fluid) - Third heart sound (S3 gallop): Ventricular dysfunction - Bibasilar crackles: Pulmonary edema

Labs: - BNP or NT-proBNP ↑: (Natriuretic peptides from ventricular stretch) - Echocardiogram: Reduced ejection fraction (EF <40% = HF with reduced EF, HFrEF) or normal EF (HF with preserved EF, HFpEF) - Albumin normal (no massive protein loss like nephrotic) - Troponin elevation: If acute MI precipitated HF

Management: 1. Acute: - IV diuretics (furosemide) for fluid overload, pulmonary edema - Vasodilators (nitroglycerin, nitroprusside) to reduce afterload - Inotropes (dobutamine, milrinone) if shock - Oxygen/intubation if respiratory failure

  1. Chronic:
    • ACE-I/ARB (GDMT cornerstone; reduce afterload, neurohormonal axis)
    • Beta-blocers (carvedilol, metoprolol) — slow HR, reduce contractility demand
    • Aldosterone antagonist (spironolactone) — RAAS inhibition
    • SGLT2 inhibitors (dapagliflozin, empagliflozin) — proven HF benefit
    • Diuretics (furosemide, torsemide) for volume management

Liver Cirrhosis (Hepatic Edema)

Mechanism: Complex; multiple Starling force abnormalities

Pathophysiology: 1. Portal hypertension (fibrosis/cirrhosis obstructs flow) → ↑ splanchnic capillary pressure (↑ Pc) 2. Decreased albumin synthesis (hepatocytes damaged) → ↓ πc 3. Splanchnic vasodilation (nitric oxide, other vasodilators ↑) → underfilling of systemic circulation → RAAS activation → Na retention

Clinical Features: - Peripheral edema: Often symmetric; worse in evening/lower extremities - Ascites: Abdominal fluid; tense, bulging abdomen; fluid wave positive - Spider angiomas, palmar erythema: Hyperestrogenism (liver can’t metabolize estrogen) - Jaundice: Bilirubin ↑ - Hepatomegaly: Cirrhotic liver may be shrunken (late cirrhosis) - Splenomegaly: Portal hypertension - Encephalopathy: Ammonia ↑ (liver dysfunction)

Labs: - Albumin LOW (<2.5 g/dL) - Bilirubin ↑ (>2 mg/dL) - INR ↑ (coagulopathy from ↓ clotting factors) - Platelets ↓ (splenomegaly from portal HTN) - AST/ALT mildly ↑ (or may be normal if burnt-out cirrhosis)

Management: 1. Address underlying liver disease: Abstain from alcohol, DAA for HCV, immunosuppression for autoimmune, etc. 2. Sodium restriction: <1.5–2 g/day (critical; Na retention is major problem) 3. Diuretics: Spironolactone (target low-dose; avoid ototoxicity) + furosemide (if needed for ascites) 4. Paracentesis: Therapeutic if tense ascites; improves breathing, comfort 5. TIPS: Transjugular intrahepatic portosystemic shunt (if refractory ascites; invasive; reserved for specific indications) 6. Liver transplant: Definitive; consider if decompensated despite medical management


Localized Edema (One Limb)

Venous Insufficiency / Deep Vein Thrombosis (DVT)

Mechanism: ↑ Pc from venous obstruction/incompetence

Venous insufficiency (Chronic): - Valvular insufficiency → retrograde flow → venous HTN in lower extremity - Edema: Unilateral (usually one leg worse); warm, non-pitting initially; may pit if severe - Associated: Varicose veins, skin changes (hyperpigmentation, ulceration)

DVT (Acute): - Thrombosis blocks venous return → ↑ capillary pressure - Edema: Sudden, unilateral (swollen >2 cm circumference vs other leg); calf pain, warmth - Risk: Immobilization, cancer, hypercoagulable state, surgery - Diagnosis: Duplex ultrasound (gold standard) - Treatment: Anticoagulation (LMWH, DOACs, warfarin)

Lymphedema

Mechanism: ↓ Lymphatic drainage → fluid accumulates in interstitium

Causes: - Primary: Congenital hypoplasia/hyperplasia of lymph vessels (rare) - Secondary: Lymph node removal (cancer surgery), radiation, infection (cellulitis worsens)

Clinical Features: - Non-pitting edema (firm, woody; doesn’t leave impression) - Bilateral in primary; unilateral in secondary - Onset: Gradual; may not appear for years post-surgery

Management: - Compression stockings (not much helps; supportive) - Lymphatic massage, elevation - Limb protection (avoid infection, trauma)


Diagnostic Approach: Edema Workup

EDEMA IDENTIFIED
    │
    ├─ HISTORY & EXAM
    │  ├─ Pitting vs non-pitting?
    │  ├─ Bilateral (generalized) vs unilateral (localized)?
    │  ├─ Onset (acute vs chronic)?
    │  ├─ Associated symptoms (SOB, orthopnea? abdominal distension?)
    │  └─ Past medical history (HF, kidney disease, liver disease, malignancy, thrombosis)
    │
    ├─ PHYSICAL EXAM
    │  ├─ JVP (elevated? → cardiac/venous congestion)
    │  ├─ Heart sounds (S3 gallop? → HF)
    │  ├─ Lung auscultation (crackles? → pulmonary edema, HF)
    │  ├─ Hepatomegaly, ascites? (→ liver disease or RV HF)
    │  ├─ Calf tenderness, warmth? (→ DVT)
    │  └─ Skin changes (hyperpigmentation, ulceration? → venous insufficiency)
    │
    ├─ LABS
    │  ├─ Albumin (↓ → nephrotic, liver disease)
    │  ├─ Urinalysis (proteinuria >3.5? → nephrotic)
    │  ├─ Cr, BUN (elevated? → kidney disease, poor perfusion)
    │  ├─ LFTs (↑ bilirubin? → liver disease)
    │  ├─ BNP/NT-proBNP (↑ → HF)
    │  └─ CBC (↓ platelets? → liver disease, splenomegaly)
    │
    ├─ IMAGING
    │  ├─ CXR (pulmonary edema? cardiomegaly? → HF)
    │  ├─ Echocardiogram (EF? systolic function? → HF assessment)
    │  ├─ Duplex ultrasound (if unilateral; rule out DVT)
    │  ├─ Abdominal ultrasound (cirrhosis findings? ascites? → liver disease)
    │  └─ Kidney biopsy if nephrotic + unclear etiology
    │
    └─ CLASSIFY & TREAT
       ├─ Nephrotic: ACE-I/ARB + diuretics + Na restriction
       ├─ Cardiac: GDMT (ACE-I, beta-blocker, aldosterone antagonist, SGLT2i)
       ├─ Hepatic: Na restriction + diuretics (spironolactone) + address liver disease
       ├─ Venous: Compression stockings, elevation; anticoagulation if DVT
       └─ Lymphatic: Compression garments, massage, elevation

Board-Style Pearls

Clinical Pearl

1. Nephrotic edema + proteinuria >3.5 → Start ACE-I/ARB immediately (reduce proteinuria + GFR protection) 2. Pulmonary edema + ↓ EF → HF; use IV diuretics + vasodilators 3. Ascites + ↓ albumin + ↑ bilirubin → Cirrhosis; Na restrict, avoid NSAIDs (acute kidney injury risk) 4. Unilateral leg edema + calf pain → DVT until proven otherwise; duplex 5. Non-pitting edema in leg → Lymphedema; compression stockings main therapy


Self-Test Questions

  1. 62F with bilateral ankle edema, proteinuria 5 g/day, albumin 2.0, Cr 1.8, BP 155/92
    • Diagnosis: Nephrotic syndrome (proteinuria >3.5 + hypoalbuminemia + edema)
    • Management: ACE-I (e.g., lisinopril 10 mg), diuretics (furosemide 40 mg), Na restrict <2 g
    • Monitor: Proteinuria reduction; BP target <120; check for RVT if membranous
  2. 48M with SOB on exertion, orthopnea, ankle edema, S3 gallop, JVP elevated, EF 28%
    • Diagnosis: HFrEF with acute decompensation (pulmonary congestion)
    • Immediate: IV furosemide, oxygen, consider vasodilators
    • Chronic: ACE-I, beta-blocker, aldosterone antagonist, SGLT2i; diuretics as needed
  3. 72M with ascites, jaundice, spider angiomas, albumin 1.8, INR 2.2, platelets 80K
    • Diagnosis: Cirrhosis (liver disease; multi-organ signs of hepatic dysfunction)
    • Management: Sodium restrict <1.5 g; spironolactone (low-dose to minimize AKI); paracentesis if tense
    • Avoid: NSAIDs (↑ AKI, renal vasoconstriction), aggressive diuretics (↑ hepatorenal syndrome)

Version 1.0 | PA/Medical student level | Updated 2026-02-28

References: KDIGO Nephrotic Syndrome Guidelines. 2022 AHA/ACC/HFSA HF Guideline. Liver Cirrhosis & Ascites Management (AASLD).